4.6 Article

PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma

Related references

Note: Only part of the references are listed.
Article Oncology

Genomic aberrations in pediatric diffuse intrinsic pontine gliomas

Katherine E. Warren et al.

NEURO-ONCOLOGY (2012)

Article Multidisciplinary Sciences

Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy

Emmanuelle Huillard et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Biochemistry & Molecular Biology

Sensitivity of malignant rhabdoid tumor cell lines to PD 0332991 is inversely correlated with p16 expression

Yoshiki Katsumi et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Commissioning a small-field biological irradiator using point, 2D, and 3D dosimetry techniques

Joseph Newton et al.

MEDICAL PHYSICS (2011)

Article Multidisciplinary Sciences

Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM

W. Ruprecht Wiedemeyer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)